Patents by Inventor MARIT L. SANDVOLD

MARIT L. SANDVOLD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof
    Patent number: 8722041
    Abstract: This invention provides monoclonal antibodies that recognize hENT1. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and/or prophylactic in disorders associated with aberrant hENT1 expression and/or activity.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: May 13, 2014
    Assignee: Governors of the University of Alberta
    Inventors: Marit L. Sandvold, Finn Myhren, Carol E. Cass, James D. Young
  • Anti-Human Equilibrative Nucleoside Transporter 1 (hENT1) Antibodies and Methods of Use Thereof
    Publication number: 20120009197
    Abstract: This invention provides monoclonal antibodies that recognize hENT1. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and/or prophylactic in disorders associated with aberrant hENT1 expression and/or activity.
    Type: Application
    Filed: June 16, 2011
    Publication date: January 12, 2012
    Inventors: MARIT L. SANDVOLD, FINN MYHREN, CAROL E. CASS, JAMES D. YOUNG